Robert W Postma
CIK 1827847 · last filed 2026-05-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$254.4K
Companies
2
Total Filings
13
Lifetime Open-Market Net
$617.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TCRT | Director | 112,562 | $2.26 | $254.4K | $487.5K | 11 | 2026-05-01 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 5,451,870 | $0.87 | $4.72M | $129.8K | 2 | 2021-09-03 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-24 | TCRT | Grant (A) | +40,000 | $0 | EDGAR |
| 2021-09-03 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Buy (P) | +75,000 | $129.8K | EDGAR |
| 2021-05-06 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.